Komzifti Capsule
Product Images NDC 84696-200

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Komzifti (NDC 84696-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kura Oncology, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zif00 0003 01)

Chemical structure diagram of ziftomenib, the active ingredient in Komzifti 200 mg capsules by Kura Oncology, Inc. The image shows the molecular framework with various rings and functional groups labeled with atomic symbols and bonds.*

FDA Label Image

Principal Display Panel (200 mg Bottle Label)

Komzifti 200 mg capsules label with active ingredient ziftomenib for oral use. The label shows the product name, strength, and dosage form prominently. It includes manufacturer Kura Oncology, Inc. and marketer Kura Oncology, Inc. and Kyowa Kirin Co., Ltd. The package contains 90 capsules and features storage instructions, usage precautions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.